Cidara Therapeutics

Cidara Therapeutics is applying its small molecule immunotherapy platform to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Our initial focus is on devastating fungal infections that often complicate cancer and transplant treatments.

Focus area
Infectious Diseases & Vaccines
Commencement date
05/06/2014